| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8758095 | European Journal of Internal Medicine | 2018 | 5 Pages |
Abstract
Urinary DHA excretion in APRT deficiency patients decreased with conventional doses of both allopurinol and febuxostat. Febuxostat was, however, significantly more efficacious than allopurinol in reducing DHA excretion in the prescribed doses. This finding, which may translate into improved outcomes of patients with APRT deficiency, should be confirmed in a larger sample.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Vidar O. Edvardsson, Hrafnhildur L. Runolfsdottir, Unnur A. Thorsteinsdottir, Inger M. Sch. Agustsdottir, G. Steinunn Oddsdottir, Finnur Eiriksson, David S. Goldfarb, Margret Thorsteinsdottir, Runolfur Palsson,